Replies to post #249 on Revance Therapeutics Inc (RVNC)

[Bickema]

For additional assurance, I’ve reviewed the BELMONT data—as well as RVNC’s phase-2 data in CD—with an ophthalmologist who’s an expert on botulinum toxin.

Hey Dew just reading through old posts and saw this little tidbit. I was wondering if there were any comments or concerns from your source that you could share with the board. Does your expert like RT002's chances?